SCHEMBL793893

SCHEMBL793893

Nc1cc2c(cc1F)CCN(c1cnccc1C(F)(F)F)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
EED O75530 1/20 0.35
MAOB P27338 2/20 0.33
PDGFRB P09619 1/20 0.33
KDR P35968 1/20 0.33
TIPARP Q7Z3E1 2/20 0.32
CYP11B1 P15538 1/20 0.32
C5AR1 P21730 1/20 0.32
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798567 0.81 CYP17A1 (0.44)
SCHEMBL798005 0.77 CYP11B2 (0.45) CYP11B2HTR2AHTR2CHTR2BCYP11B1
SCHEMBL798810 0.75 HTR2A (0.34) CYP11B2HTR2AHTR2CHTR2BEED
SCHEMBL22669012 0.69 NOTUM (0.48) MAPTHTTKDR
SCHEMBL793474 0.69 CYP11B2 (0.41) CYP11B2HTR2AHTR2CHTR2BLMNA
SCHEMBL22668992 0.68 NOTUM (0.47) MAPTHTTKDR
SCHEMBL794441 0.68 CYP11B2 (0.44) CYP11B2HTR2AHTR2CHTR2BCYP11B1
SCHEMBL807799 0.68 CYP11B2 (0.57) CYP11B2HTR2AHTR2CCYP11B1OPRM1
SCHEMBL794272 0.67 PHGDH (0.43) HTR2AHTR2CPDGFRBKDR
SCHEMBL793875 0.67 TRPV3 (0.41) HTR2AHTR2CPDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed